Tumor Diagnosis and Treatment Based on Stimuli-Responsive Aggregation of Gold Nanoparticles

Abstract

Gold nanomaterials have been used in the diagnosis and treatment of different tumors due to their unique physical and chemical properties. Among them, gold nanoparticles with stimuli-responsive aggregation functions have attracted extensive attention because they can meet the unique needs of tumor diagnosis and treatment at different stages through structural changes. However, how to effectively modify gold nanoparticles to achieve structural transformation for specific stimuli, and the role of corresponding structural transformation in improving the effect of diagnosis and treatment still lack systematic summary. In this review, we comprehensively summarized the current strategies for inducing gold nanoparticles aggregation and its advances in tumor diagnosis and treatment.

Keywords

gold nanoparticles / stimuli-responsive aggregation / tumor diagnosis and treatment

References

[1] a) B. Yin, W. K. H. Ho, X. Xia, et al., “A Multilayered Mesoporous Gold Nanoarchitecture for Ultraeffective Near-Infrared Light-Controlled Chemo/Photothermal Therapy for Cancer Guided by SERS Imaging,” Small 19 (2023): 2206762. b) H. Sheng, J. Wang, J. Huang, et al., “Strong Synergy Between Gold Nanoparticles and Cobalt Porphyrin Induces Highly Efficient Photocatalytic Hydrogen Evolution,” Nature Communications 14 (2023): 1528. c) P. Kesharwani, R. Ma, L. Sang, et al., “Gold Nanoparticles and Gold Nanorods in the Landscape of Cancer Therapy,” Molecular Cancer 22 (2023): 98.

[2] a) I.-C. Sun, D. S. Dumani, and S. Y. Emelianov, “Applications of the Photocatalytic and Photoacoustic Properties of Gold Nanorods in Contrast-Enhanced Ultrasound and Photoacoustic Imaging,” ACS Nano 18 (2024): 3575. b) V. P. Nguyen, W. Qian, J. Zhe, et al., “Renally Clearable Ultraminiature Chain-Like Gold Nanoparticle Clusters for Multimodal Molecular Imaging of Choroidal Neovascularization,” Advanced Materials 35 (2023): 2302069. c) Y.-S. Chen, Y. Zhao, S. J. Yoon, S. S. Gambhir, and S. Emelianov, “Miniature Gold Nanorods for Photoacoustic Molecular Imaging in the Second Near-Infrared Optical Window,” Nature Nanotechnology 14 (2019): 465.

[3] a) A. N. Smirnov, S. F. Aslanov, D. V. Danilov, O. Y. Kurapova, and E. V. Solovyeva, “One-Pot Synthesis of Silica-Coated Gold Nanostructures Loaded With Cyanine 5.5 for Cell Imaging by SERS Spectroscopy,” Nanomaterials 13 (2023): 1267. b) G. I. Dar, E. Xifre-Perez, and L. F. Marsal, “Fabrication of Au-Decorated Al Nanoconcavities Platform for Augmented SERS,” Advanced Materials Interfaces 10 (2023): 2300560. c) M. Shiota, M. Naya, T. Yamamoto, et al., “Gold-Nanofève Surface-Enhanced Raman Spectroscopy Visualizes Hypotaurine as a Robust Anti-Oxidant Consumed in Cancer Survival,” Nature Communications 9 (2018): 1561. d) G. Awiaz, J. Lin, and A. Wu, “Recent Advances of Au@Ag Core–Shell SERS-Based Biosensors,” Exploration 3 (2023): 20220072.

[4] K. C. Kwon, E. Jo, Y. W. Kwon, et al., “Superparamagnetic Gold Nanoparticles Synthesized on Protein Particle Scaffolds for Cancer Theragnosis,” Advanced Materials 29 (2017): 1701146.

[5] a) M. Sivasubramanian, C.-H. Chu, Y. Hsia, et al., “Illuminating and Radiosensitizing Tumors With 2DG-Bound Gold-Based Nanomedicine for Targeted CT Imaging and Therapy,” Nanomaterials 13 (2023): 1790. b) M. Moghiseh, E. Searle, D. Dixit, et al., “Spectral Photon-Counting CT Imaging of Gold Nanoparticle Labelled Monocytes for Detection of Atherosclerosis: A Preclinical Study,” Diagnostics 13 (2023): 499. c) A. Khorasani, D. Shahbazi-Gahrouei, and A. Safari, “Recent Metal Nanotheranostics for Cancer Diagnosis and Therapy: A Review,” Diagnostics 13 (2023): 833.

[6] a) X. Yan, K. Li, T.-Q. Xie, et al., “Bioorthogonal “Click and Release” Reaction-Triggered Aggregation of Gold Nanoparticles Combined With Released Lonidamine for Enhanced Cancer Photothermal Therapy,” Angewandte Chemie International Edition 63 (2024): 202318539. b) R. Wei, Y. Li, P. Gao, et al., “A Gold Nanoparticle Engineered Metal–Organic Framework Nanoreactor for Combined Ferroptosis and Mild Photothermal Therapy,” Chemical Communications 59 (2023): 6509. c) A. V. Povolotskiy, O. S. Smirnova, D. A. Soldatova, A. V. Povolotckaia, and D. A. Lukyanov, “High-Precision Optical Excited Heaters Based on Au Nanoparticles and Water-Soluble Porphyrin,” Metals 13 (2023): 1851. d) H. Kim, Y. Baek, T. Ha, et al., “Gold Nanoparticle-Carrying T Cells for the Combined Immuno-Photothermal Therapy,” Small 19 (2023): 2301377.

[7] a) A. S. Schwartz-Duval, Y. Mackeyev, I. Mahmud, et al., “Intratumoral Biosynthesis of Gold Nanoclusters by Pancreatic Cancer to Overcome Delivery Barriers to Radiosensitization,” ACS Nano 18 (2024): 1865. b) A. Stergioula, E. Pantelis, V. Kontogeorgakos, A. C. Lazaris, and G. Agrogiannis, “Understanding the Role of Radio-Sensitizing Nanoparticles in Enhancing Pathologic Response in Soft Tissue Sarcomas,” Cancers 15 (2023): 5572. c) S. Soares, I. Faria, F. Aires, et al., “Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines,” International Journal of Molecular Sciences 24 (2023): 4122. d) L. R. H. Gerken, M. E. Gerdes, M. Pruschy, and I. K. Herrmann, “Prospects of Nanoparticle-Based Radioenhancement for Radiotherapy,” Materials Horizons 10 (2023): 4059.

[8] a) S. Samanta and V. K. Arivarasan, “A Multifunctional Drug Delivery Cargo: Folate-Driven Gold Nanoparticle-vitamin B Complex for next-generation Drug Delivery,” Materials Letters 355 (2024): 135425. b) A. Uzel, L. Agiotis, A. Baron, et al., “Single Pulse Nanosecond Laser-Stimulated Targeted Delivery of Anti-Cancer Drugs From Hybrid Lipid Nanoparticles Containing 5 nm Gold Nanoparticles,” Small 19 (2023): 2305591. c) J. L. Carreon Gonzalez, P. E. Garcia Casillas, and C. Chapa Gonzalez, “Gold Nanoparticles as Drug Carriers: The Role of Silica and PEG as Surface Coatings in Optimizing Drug Loading,” Micromachines 14 (2023): 451.

[9] a) D. Xu, L. Wu, H. Yao, and L. Zhao, “Catalase-Like Nanozymes: Classification, Catalytic Mechanisms, and Their Applications,” Small 18 (2022): 2203400. b) Y. Li, R. Fu, Z. Duan, C. Zhu, and D. Fan, “Adaptive Hydrogels Based on Nanozyme With Dual-Enhanced Triple Enzyme-Like Activities for Wound Disinfection and Mimicking Antioxidant Defense System,” Advanced Healthcare Materials 11 (2022): 2101849. c) J. Lee, H. Liao, Q. Wang, et al., “Exploration of Nanozymes in Viral Diagnosis and Therapy,” Exploration 2 (2022): 20210086.

[10] G. F. Paciotti, L. Myer, D. Weinreich, et al., “Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery,” Drug Delivery 11 (2004): 169.

[11] E. Boisselier and D. Astruc, “Gold Nanoparticles in Nanomedicine: Preparations, Imaging, Diagnostics, Therapies and Toxicity,” Chemical Society Reviews 38 (2009): 1759.

[12] L. Dykman and N. Khlebtsov, “Gold Nanoparticles in Biomedical Applications: Recent Advances and Perspectives,” Chemical Society Reviews 41 (2012): 2256.

[13] K. Saha, S. S. Agasti, C. Kim, X. Li, and V. M. Rotello, “Gold Nanoparticles in Chemical and Biological Sensing,” Chemical Reviews 112 (2012): 2739.

[14] S. Her, D. A. Jaffray, and C. Allen, “Gold Nanoparticles for Applications in Cancer Radiotherapy: Mechanisms and Recent Advancements,” Advanced Drug Delivery Reviews 109 (2017): 84.

[15] a) E. M. Higbee-Dempsey, A. Amirshaghaghi, M. J. Case, et al., “Biodegradable Gold Nanoclusters With Improved Excretion due to pH-Triggered Hydrophobic-to-Hydrophilic Transition,” Journal of the American Chemical Society 142 (2020): 7783. b) D. Huo, S. Liu, C. Zhang, et al., “Hypoxia-Targeting, Tumor Microenvironment Responsive Nanocluster Bomb for Radical-Enhanced Radiotherapy,” ACS Nano 11 (2017): 10159.

[16] a) L. Zhao, W. Yuan, C. Y. Ang, et al., “Silica-Polymer Hybrid With Self-Assembled PEG Corona Excreted Rapidly via a Hepatobiliary Route,” Advanced Functional Materials 26 (2016): 3036. b) J. Song, X. Yang, O. Jacobson, et al., “Ultrasmall Gold Nanorod Vesicles With Enhanced Tumor Accumulation and Fast Excretion From the Body for Cancer Therapy,” Advanced Materials 27 (2015): 4910.

[17] a) J. Waitkus, Y. Chang, L. Liu, et al., “Gold Nanoparticle Enabled Localized Surface Plasmon Resonance on Unique Gold Nanomushroom Structures for on-Chip CRISPR-Cas13a Sensing,” Advanced Materials Interfaces 10 (2023): 2201261. b) V. Semwal, O. R. Jensen, O. Bang, and J. Janting, “Investigation of Performance Parameters of Spherical Gold Nanoparticles in Localized Surface Plasmon Resonance Biosensing,” Micromachines 14 (2023): 1717. c) H.-M. Kim, H.-J. Kim, J.-H. Park, and S.-K. Lee, “High-performance Biosensor Using a Sandwich Assay via Antibody-conjugated Gold Nanoparticles and fiber-optic Localized Surface Plasmon Resonance,” Analytica Chimica Acta 1213 (2022): 339960. d) A. S. Dileseigres, Y. Prado, and O. Pluchery, “How to Use Localized Surface Plasmon for Monitoring the Adsorption of Thiol Molecules on Gold Nanoparticles?,” Nanomaterials 12 (2022): 292.

[18] a) D. Sang, X. Luo, and J. Liu, “Biological Interaction and Imaging of Ultrasmall Gold Nanoparticles,” Nano-Micro Letters 16 (2024): 44. b) N. Lyu, B. Sun, A. Tukova, Q. Zhang, Z. Gu, and Y. Wang, “In Situ Synthesis of Gold Nanoparticles on Layered Double Hydroxide Nanoparticles for Multiplexing Molecular Imaging of Single Cells,” Materials Today Chemistry 33 (2023): 101698. c) Y. Huang, L. Li, S. Yang, et al., “HA-AuNPs/FDF for Highly Sensitive Detection of Hyaluronidase, Tumor-targeting Fluorescence Cell Imaging and Phototherapy,” Acta Chimica Sinica 81 (2023): 1687. d) N. E.-A. El-Naggar, N. H. Rabei, M. F. Elmansy, et al., “Artificial Neural Network Approach for Prediction of AuNPs Biosynthesis by Streptomyces Flavolimosus, Characterization, Antitumor Potency in-vitro and in-vivo Against Ehrlich Ascites Carcinoma ,” Scientific Reports 13 (2023): 12686.

[19] a) H.-T. D. Bui, Y. Park, Y. M. Jung, S. Y. Chew, and H. S. Yoo, “Reactive Oxygen Species-responsive Clicked Assembly of Gold Nanoparticles to Enhance Photothermal Therapy,” Journal of Materials Chemistry B 11 (2023): 6961. b) J. Kadkhoda, A. Aghanejad, B. Safari, J. Barar, S. H. Rasta, and S. Davaran, “Aptamer-conjugated Gold Nanoparticles for Targeted Paclitaxel Delivery and Photothermal Therapy in Breast Cancer,” Journal of Drug Delivery Science and Technology 67 (2022): 102954. c) V. Frantellizzi, V. Verrina, C. Raso, et al., “99mTc-labeled Keratin Gold-nanoparticles in a Nephron-Like Microfluidic Chip for Photo-thermal Therapy Applications,” Materials Today Advances 16 (2022): 100286.

[20] Y. Liu, P. Bhattarai, Z. Dai, and X. Chen, “Photothermal Therapy and Photoacoustic Imaging via Nanotheranostics in Fighting Cancer,” Chem. Soc. Rev. 48 (2019): 2053.

[21] a) Y. Wang, F. Wang, Y. Shen, Q. He, and S. Guo, “Tumor-specific Disintegratable Nanohybrids Containing Ultrasmall Inorganic Nanoparticles: From Design and Improved Properties to Cancer Applications,” Materials Horizons 5 (2018): 184. b) D. Cabuzu, A. Cirja, R. Puiu, and A. M. Grumezescu, “Biomedical Applications of Gold Nanoparticles,” Current Topics in Medicinal Chemistry 15 (2015): 1605.

[22] M. Longmire, P. L. Choyke, and H. Kobayashi, “Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats,” Nanomedicine 3 (2008): 703.

[23] a) J. Li, H. Liu, J. Ming, et al., “The Biobehavior, Biocompatibility and Theranostic Application of SPNS and Pd@Au Nanoplates in Rats and Rabbits,” Chemical Science 10 (2019): 1677. b) W. Gu, Y. Zhao, S. Zhuang, et al., “Unravelling the Structure of a Medium-Sized Metalloid Gold Nanocluster and Its Filming Property,” Angewandte Chemie International Edition 60 (2021): 11184.

[24] G. Moreno-Alcántar, P. Picchetti, and A. Casini, “Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems,” Angewandte Chemie International Edition 62 (2023): e202218000.

[25] D. Liu, L. Liu, F. Liu, M. Zhang, P. Wei, and T. Yi, “HOCl-Activated Aggregation of Gold Nanoparticles for Multimodality Therapy of Tumors,” Advancement of Science 8 (2021): 2100074.

[26] H. Aldewachi, T. Chalati, M. N. Woodroofe, N. Bricklebank, B. Sharrack, and P. Gardiner, “Gold Nanoparticle-based Colorimetric Biosensors,” Nanoscale 10 (2018): 18.

[27] J. Fan, Y. Cheng, and M. Sun, “Functionalized Gold Nanoparticles: Synthesis, Properties and Biomedical Applications,” Chemical Record 20 (2020): 1474.

[28] P. K. Kundu, D. Samanta, R. Leizrowice, et al., “Light-controlled Self-assembly of Non-photoresponsive Nanoparticles,” Nature Chemistry 7 (2015): 646.

[29] R. Klajn, P. J. Wesson, K. J. Bishop, and B. A. Grzybowski, “Writing Self-Erasing Images Using Metastable Nanoparticle “Inks”,” Angewandte Chemie International Edition 48 (2009): 7035.

[30] D. Manna, T. Udayabhaskararao, H. Zhao, and R. Klajn, “Orthogonal Light-Induced Self-Assembly of Nanoparticles Using Differently Substituted Azobenzenes,” Angewandte Chemie International Edition 54 (2015): 12394.

[31] D. Liu, W. Chen, K. Sun, et al., “Resettable, Multi-Readout Logic Gates Based on Controllably Reversible Aggregation of Gold Nanoparticles,” Angewandte Chemie International Edition 50 (2011): 4103.

[32] Y. Shiraishi, E. Shirakawa, K. Tanaka, H. Sakamoto, S. Ichikawa, and T. Hirai, “Spiropyran-Modified Gold Nanoparticles: Reversible Size Control of Aggregates by UV and Visible Light Irradiations,” ACS Applied Materials & Interfaces 6 (2014): 7554.

[33] Y. Shiraishi, K. Tanaka, E. Shirakawa, et al., “Light-Triggered Self-Assembly of Gold Nanoparticles Based on Photoisomerization of Spirothiopyran,” Angewandte Chemie International Edition 52 (2013): 8304.

[34] J. Lai, Y. Xu, X. Mu, et al., “Light-triggered Covalent Assembly of Gold Nanoparticles in Aqueous Solution,” Chemical Communications 47 (2011): 3822.

[35] H. He, M. Feng, Q. Chen, X. Zhang, and H. Zhan, “Light-Induced Reversible Self-Assembly of Gold Nanoparticles Surface-Immobilized With Coumarin Ligands,” Angewandte Chemie International Edition 55 (2016): 936.

[36] X. Guo, D. Zhang, T. Wang, and D. Zhu, “Reversible Regulation of Pyrene Excimer Emission by Light and Metal Ions in the Presence of Photochromic Spiropyran: Toward Creation of a New Molecular Logic Circuit,” Chemical Communications 7 (2003): 914.

[37] S. Wu, S. Y. Tan, C. Y. Ang, Z. Luo, and Y. Zhao, “Oxidation-triggered Aggregation of Gold Nanoparticles for Naked-eye Detection of Hydrogen Peroxide,” Chemical Communications 52 (2016): 3508.

[38] J. Kim, A. M. Yu, K. P. Kubelick, and S. Y. Emelianov, “Gold Nanoparticles Conjugated With DNA Aptamer for Photoacoustic Detection of human Matrix Metalloproteinase-9,” Photoacoustics 25 (2022): 100307.

[39] a) C. J. Kim, D. I. Lee, C. Kim, K. Lee, C. H. Lee, and I. S. Ahn, “Gold Nanoparticles-Based Colorimetric Assay for Cathepsin B Activity and the Efficiency of Its Inhibitors,” Analytical Chemistry 86 (2014): 3825. b) P. Chen, R. Selegard, D. Aili, and B. Liedberg, “Peptide Functionalized Gold Nanoparticles for Colorimetric Detection of Matrilysin (MMP-7) Activity,” Nanoscale 5 (2013): 8973. c) J. Y. Piao and D. S. Chung, “Novel Colorimetric Assay of LSD1 Activity Using Gold Nanoparticles,” Analyst 137 (2012): 2669. d) Y. Pan, M. Guo, Z. Nie, et al., “Colorimetric Detection of Apoptosis Based on Caspase-3 Activity Assay Using Unmodified Gold Nanoparticles,” Chemical Communications 48 (2012): 997. e) Y. C. Chuang, J. C. Li, S. H. Chen, et al., “An Optical Biosensing Platform for Proteinase Activity Using Gold Nanoparticles,” Biomaterials 31 (2010): 6087.

[40] J. H. Lin and W. L. Tseng, “Ultrasensitive Detection of Target Analyte-induced Aggregation of Gold Nanoparticles Using Laser-induced Nanoparticle Rayleigh Scattering,” Talanta 132 (2015): 44.

[41] L. E. Cole, R. D. Ross, J. M. Tilley, T. Vargo-Gogola, and R. K. Roeder, “Gold Nanoparticles as Contrast Agents in X-ray Imaging and Computed Tomography,” Nanomedicine 10 (2015): 321.

[42] W. Yu, M. Shevtsov, X. Chen, and H. Gao, “Advances in Aggregatable Nanoparticles for Tumor-targeted Drug Delivery,” Chinese Chemical Letters 31 (2020): 1366.

[43] W. Yu, R. Liu, Y. Zhou, and H. Gao, “Size-Tunable Strategies for a Tumor Targeted Drug Delivery System,” ACS Central Science 6 (2020): 100.

[44] F. Li, J. Lu, X. Kong, T. Hyeon, and D. Ling, “Dynamic Nanoparticle Assemblies for Biomedical Applications,” Advanced Materials 29 (2017): 1605897.

[45] S. Ruan, C. Hu, X. Tang, et al., “Increased Gold Nanoparticle Retention in Brain Tumors by In Situ Enzyme-Induced Aggregation,” ACS Nano 10 (2016): 10086.

[46] X. Cheng, X. Zhou, J. Xu, et al., “Furin Enzyme and pH Synergistically Triggered Aggregation of Gold Nanoparticles for Activated Photoacoustic Imaging and Photothermal Therapy of Tumors,” Analytical Chemistry 93 (2021): 9277.

[47] X. Cheng, R. Sun, L. Yin, Z. Chai, H. Shi, and M. Gao, “Light-Triggered Assembly of Gold Nanoparticles for Photothermal Therapy and Photoacoustic Imaging of Tumors in Vivo,” Advanced Materials 29 (2017): 1604894.

[48] Q. Mao, J. Fang, A. Wang, et al., “Aggregation of Gold Nanoparticles Triggered by Hydrogen Peroxide-Initiated Chemiluminescence for Activated Tumor Theranostics,” Angewandte Chemie International Edition 60 (2021): 23805.

[49] F. Chen, M. Wang, Z. Du, X. Pu, and B. Zhu, “131I Labeled pH-Responsive Gold Nanoparticles for Bimodal Tumor Diagnosis,” Materials Letters 330 (2023): 133202.

[50] M. Sun, F. Liu, Y. Zhu, et al., “Salt-Induced Aggregation of Gold Nanoparticles for Photoacoustic Imaging and Photothermal Therapy of Cancer,” Nanoscale 8 (2016): 4452.

[51] L. An, M. Cao, X. Zhang, J. Lin, Q. Tian, and S. Yang, “pH and Glutathione Synergistically Triggered Release and Self-Assembly of Au Nanospheres for Tumor Theranostics,” ACS Applied Material Interfaces 12 (2020): 8050.

[52] S. Jung, J. Nam, S. Hwang, et al., “Theragnostic pH-Sensitive Gold Nanoparticles for the Selective Surface Enhanced Raman Scattering and Photothermal Cancer Therapy,” Analytical Chemistry 85 (2013): 7674.

[53] X. Gao, Q. Yue, Z. Liu, et al., “Guiding Brain-Tumor Surgery via Blood-Brain-Barrier-Permeable Gold Nanoprobes With Acid-Triggered MRI/SERRS Signals,” Advanced Materials 29 (2017): 1603917.

[54] Y. Zhang, J. Chang, F. Huang, et al., “Acid-Triggered in Situ Aggregation of Gold Nanoparticles for Multimodal Tumor Imaging and Photothermal Therapy,” ACS Biomaterials Science & Engineering 5 (2019): 1589.

[55] H. Fang, Y. Chen, Z. Jiang, W. He, and Z. Guo, “Fluorescent Probes for Biological Species and Microenvironments: From Rational Design to Bioimaging Applications,” Accounts of Chemical Research 56 (2023): 258.

[56] a) M. Kim, K. P. Kubelick, A. M. Yu, et al., “Regulating Interparticle Proximity in Plasmonic Nanosphere Aggregates to Enhance Photoacoustic Response and Photothermal Stability,” Advanced Functional Materials 34 (2024): 2313963. b) H. Wang, L. Yan, C. Ma, and Y. Han, “An Extremum-guided Interpolation for Sparsely Sampled Photoacoustic Imaging,” Photoacoustics 32 (2023): 100535. c) X. Sun, L. Xu, H.-D. Xu, et al., “Intracellular Nitroreductase-Triggered “on” and “Enhanced” Photoacoustic Signals for Sensitive Imaging of Tumor Hypoxia,” Advanced Healthcare Materials 13 (2024): 2303472.

[57] Y. Wu, M. R. K. Ali, K. Chen, N. Fang, and M. A. El-Sayed, “Gold Nanoparticles in Biological Optical Imaging,” Nano Today 24 (2019): 120.

[58] a) X. Su, X. Liu, Y. Xie, et al., “Integrated SERS-Vertical Flow Biosensor Enabling Multiplexed Quantitative Profiling of Serological Exosomal Proteins in Patients for Accurate Breast Cancer Subtyping,” ACS Nano 17 (2023): 4077. b) Q. Li, H. Huo, Y. Wu, et al., “Design and Synthesis of SERS Materials for in Vivo Molecular Imaging and Biosensing,” Advancement of Science 10 (2023): 2202051. c) T. Itoh, M. Prochazka, Z.-C. Dong, et al., “Toward a New Era of SERS and TERS at the Nanometer Scale: From Fundamentals to Innovative Applications,” Chem. Rev. 123 (2023): 1552.

[59] M. K. Hossain, H.-Y. Cho, and J.-W. Choi, “Gold Nanosphere-Deposited Substrate for Distinguishing of Breast Cancer Subtypes Using Surface-Enhanced Raman Spectroscopy,” Journal of Nanoscience and Nanotechnology 16 (2016): 6299.

[60] K. Xu, R. Zhou, K. Takei, and M. Hong, “Toward Flexible Surface-Enhanced Raman Scattering (SERS) Sensors for Point-of-Care Diagnostics,” Advancement of Science 6 (2019): 1900925.

[61] a) X. Xiao, H. Cai, Q. Huang, et al. Bioact Mater 19 (2023): 538. b) C.-M. Feng, Y. Yan, G. Chen, et al., “Multimodal Transformer for Accelerated MR Imaging,” Ieee Transactions on Medical Imaging 42 (2023): 2804.

[62] a) J. E. Iglesias, B. Billot, Y. Balbastre, et al., “SynthSR: A Public AI Tool to Turn Heterogeneous Clinical Brain Scans Into High-resolution T1-weighted Images for 3D Morphometry,” Science Advances 9 (2023): eadd3607. b) X. Huang, B. Sheng, H. Tian, et al., “Real-time SERS Monitoring Anticancer Drug Release Along With SERS/MR Imaging for pH-sensitive Chemo-phototherapy,” Acta Pharm Sin B 13 (2023): 1303.

[63] C. Wang, J. Zhang, S. Song, et al., “Imaging Epileptic Foci in Mouse Models via a Low-density Lipoprotein Receptor-related Protein-1 Targeting Strategy,” EBioMedicine 63 (2021): 103156.

[64] a) J. Greffier, N. Villani, D. Defez, D. Dabli, and S. Si-Mohamed, “Spectral CT Imaging: Technical Principles of Dual-energy CT and Multi-energy Photon-counting CT,” Diagn Interv Imaging 104 (2023): 167. b) T. Flohr, M. Petersilka, A. Henning, S. Ulzheimer, J. Ferda, and B. Schmidt, “Photon-counting CT Review,” Phys Med 79 (2020): 126.

[65] a) K. Yang, X. Wang, C. Song, et al., “The Role of Lipid Metabolic Reprogramming in Tumor Microenvironment,” Theranostics 13 (2023): 1774. b) T. Hirz, S. Mei, H. Sarkar, et al., “Dissecting the Immune Suppressive human Prostate Tumor Microenvironment via Integrated Single-cell and Spatial Transcriptomic Analyses,” Nature Communications 14 (2023): 663.

[66] M. Stubbs, P. M. J. McSheehy, and J. R. Griffiths, “Causes and Consequences of Acidic pH in Tumors: A Magnetic Resonance Study,” Advances in Enzyme Regulation 39 (1999): 13.

[67] a) D. N. Li, S. P. Matthews, A. N. Antoniou, D. Mazzeo, and C. Watts, “Multistep Autoactivation of Asparaginyl Endopeptidase in Vitro and in Vivo,” Journal of Biological Chemistry 278 (2003): 38980. b) K. H. Hammerich, T. F. Donahue, I. L. Rosner, et al., “Alkaline Phosphatase Velocity Predicts Overall Survival and Bone Metastasis in Patients With Castration-resistant Prostate Cancer,” Urologic Oncology 35 (2017): 460.e21. c) S. Rao, A. Snaith, D. Marino, et al., “Tumour-derived Alkaline Phosphatase Regulates Tumour Growth, Epithelial Plasticity and Disease-free Survival in Metastatic Prostate Cancer,” British Journal of Cancer 116 (2017): 227. d) M. Groblewska, B. Mroczko, M. Gryko, et al., “Serum Levels and Tissue Expression of Matrix Metalloproteinase 2 (MMP-2) and Tissue Inhibitor of Metalloproteinases 2 (TIMP-2) in Colorectal Cancer Patients,” Tumor Biol 35 (2014): 3793. e) D. F. Quail and J. A. Joyce, “Microenvironmental Regulation of Tumor Progression and Metastasis,” Nature Medicine 19 (2013): 1423. f) L. Yin, H. Sun, H. Zhang, et al., “Quantitatively Visualizing Tumor-Related Protease Activity in Vivo Using a Ratiometric Photoacoustic Probe,” Journal of the American Chemical Society 141 (2019): 3265. g) A. Bhardwaj, J. Kaur, M. Wuest, and F. Wuest, “In Situ Click Chemistry Generation of Cyclooxygenase-2 Inhibitors,” Nature Communications 8 (2017): 1. h) X. Gao, Y. Liu, Y. Li, et al., “TGase-induced Intracellular Aggregation of Fe 3 O 4 Nanoparticles for Increased Retention and Enhanced T2 MRI,” Materials Chemistry Frontiers 3 (2019): 1365.

[68] a) Y. Yang, J. Huang, X. Yang, et al., “FRET Nanoflares for Intracellular mRNA Detection: Avoiding False Positive Signals and Minimizing Effects of System Fluctuations,” Journal of the American Chemical Society 137 (2015): 8340. b) D. P. Bartel, “MicroRNAs,” Cell 116 (2004): 281. c) J. Krützfeldt, N. Rajewsky, R. Braich, et al., “Silencing of microRNAs in Vivo With ‘Antagomirs’,” Nature 438 (2005): 685. d) C. J. Cheng, R. Bahal, I. A. Babar, et al., “MicroRNA Silencing for Cancer Therapy Targeted to the Tumour Microenvironment,” Nature 518 (2015): 107.

[69] a) A. Bononi, C. Giorgi, S. Patergnani, et al., “BAP1 regulates IP3R3-mediated Ca2+ Flux to Mitochondria Suppressing Cell Transformation,” Nature 546 (2017): 549. b) S. Kuchay, C. Giorgi, D. Simoneschi, et al., “PTEN Counteracts FBXL2 to Promote IP3R3- and Ca2+-mediated Apoptosis Limiting Tumour Growth,” Nature 546 (2017): 554. c) H. L. Roderick and S. J. Cook, “Ca2+ signalling Checkpoints in Cancer: Remodelling Ca2+ for Cancer Cell Proliferation and Survival,” Nature Reviews Cancer 8 (2008): 361.

[70] J. Nam, N. Won, H. Jin, H. Chung, and S. Kim, “pH-Induced Aggregation of Gold Nanoparticles for Photothermal Cancer Therapy,” Journal of the American Chemical Society 131 (2009): 13639.

[71] J. Nam, W. G. La, S. Hwang, et al., “pH-Responsive Assembly of Gold Nanoparticles and “Spatiotemporally Concerted” Drug Release for Synergistic Cancer Therapy,” ACS Nano 7 (2013): 3388.

[72] S. Kang, S. H. Bhang, S. Hwang, et al., “Mesenchymal Stem Cells Aggregate and Deliver Gold Nanoparticles to Tumors for Photothermal Therapy,” ACS Nano 9 (2015): 9678.

[73] X. Liu, Y. Chen, H. Li, et al., “Enhanced Retention and Cellular Uptake of Nanoparticles in Tumors by Controlling Their Aggregation Behavior,” ACS Nano 7 (2013): 6244.

[74] Y. Zhang, F. Huang, C. Ren, et al., “Enhanced Radiosensitization by Gold Nanoparticles With Acid-Triggered Aggregation in Cancer Radiotherapy,” Advancement of Science 6 (2019): 1801806.

[75] a) R. Xie, Y. Wang, F. Tong, et al., “Hsp70-Targeting and Size-Tunable Nanoparticles Combine With PD-1 Checkpoint Blockade to Treat Glioma,” Small 19 (2023): 2300570. b) S. Luan, R. Xie, Y. Yang, et al., “Acid-Responsive Aggregated Gold Nanoparticles for Radiosensitization and Synergistic Chemoradiotherapy in the Treatment of Esophageal Cancer,” Small 18 (2022): 2200115.

[76] Y. Tan, M. Chen, H. Chen, J. Wu, and J. Liu, “Enhanced Ultrasound Contrast of Renal-Clearable Luminescent Gold Nanoparticles,” Angewandte Chemie International Edition 60 (2021): 11713.

[77] R. Jin, Z. Liu, Y. Bai, Y. Zhou, J. J. Gooding, and X. Chen, “Core-Satellite Mesoporous Silica-Gold Nanotheranostics for Biological Stimuli Triggered Multimodal Cancer Therapy,” Advanced Functional Materials 28 (2018): 1801961.

[78] S. Yang, D. Yao, Y. Wang, W. Yang, B. Zhang, and D. Wang, “Enzyme-triggered Self-assembly of Gold Nanoparticles for Enhanced Retention Effects and Photothermal Therapy of Prostate Cancer,” Chemical Communications 54 (2018): 9841.

[79] J. Chen, Y. Ma, W. Du, et al., “Furin-Instructed Intracellular Gold Nanoparticle Aggregation for Tumor Photothermal Therapy,” Advanced Functional Materials 30 (2020): 2001566.

[80] R. Xie, S. Ruan, J. Liu, et al., “Furin-instructed Aggregated Gold Nanoparticles for Re-educating Tumor Associated Macrophages and Overcoming Breast Cancer Chemoresistance,” Biomaterials 275 (2021): 120891.

[81] S. Ruan, R. Xie, L. Qin, et al., “Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined With Anti-PD-L1 Antibody for Improved Glioma Treatment,” Nano Letters 19 (2019): 8318.

[82] K. Yang, Y. Liu, Y. Wang, et al., “Enzyme-induced in Vivo Assembly of Gold Nanoparticles for Imaging-guided Synergistic Chemo-photothermal Therapy of Tumor,” Biomaterials 223 (2019): 119460.

[83] T. Liu, R. Jin, P. Yuan, Y. Bai, B. Cai, and X. Chen, “Intracellular Enzyme-Triggered Assembly of Amino Acid-Modified Gold Nanoparticles for Accurate Cancer Therapy With Multimode,” ACS Applied Materials & Interfaces 11 (2019): 28621.

[84] T. Liu, M. Zhu, X. Chang, et al., “Tumor-Specific Photothermal-Therapy-Assisted Immunomodulation via Multiresponsive Adjuvant Nanoparticles,” Advanced Materials 35 (2023): 2300086.

[85] Z. Zhang, X. Niu, X. Feng, et al., “Construction of a pH/TGase “Dual Key”-Responsive Gold Nano-radiosensitizer With Liver Tumor-Targeting Ability,” ACS Biomaterials Science & Engineering 7 (2021): 3434.

[86] S. Yu, Y. Zhou, Y. Sun, et al., “Endogenous mRNA Triggered DNA-Au Nanomachine for In Situ Imaging and Targeted Multimodal Synergistic Cancer Therapy,” Angewandte Chemie International Edition 60 (2021): 5948.

[87] X. Wang, T. Yang, Z. Yu, et al., “Intelligent Gold Nanoparticles With Oncogenic MicroRNA-Dependent Activities to Manipulate Tumorigenic Environments for Synergistic Tumor Therapy,” Advanced Materials 34 (2022): e2110219.

[88] X. Guo, Q. Su, T. Liu, et al., “Intelligent Gold Nanoparticles for Synergistic Tumor Treatment via Intracellular Ca2+ Regulation and Resulting On-Demand Photothermal Therapy,” Chemical Engineering Journal 433 (2022): 133850.

[89] X. Chang, X. Tang, J. Liu, et al., “Precise Starving Therapy via Physiologically Dependent Photothermal Conversion Promoted Mitochondrial Calcification Based on Multi-Functional Gold Nanoparticles for Effective Tumor Treatment,” Advanced Functional Materials 33 (2023): 2303596.

[90] X. Chang, X. Tang, W. Tang, et al., “Synergistic Regulation of Targeted Organelles in Tumor Cells to Promote Photothermal-Immunotherapy Using Intelligent Core-Satellite-Like Nanoparticles for Effective Treatment of Breast Cancer,” Small 20 (2024): 2400069.

[91] T. Yin, T. Yang, L. Chen, et al., “Intelligent Gold Nanoparticles for Malignant Tumor Treatment via Spontaneous Copper Manipulation and On-Demand Photothermal Therapy Based on Copper Induced Click Chemistry,” Acta Biomaterialia 166 (2023): 485.

[92] F. Liu, T. Yang, X. Chang, et al., “Intelligent Gold Nanocluster for Effective Treatment of Malignant Tumor via Tumor-Specific Photothermal-Chemodynamic Therapy With AIE Guidance,” National Science Review 11 (2024): nwae113.

[93] a) Z. Mazidi, S. Javanmardi, S. M. Naghib, and Z. Mohammadpour, “Smart Stimuli-Responsive Implantable Drug Delivery Systems for Programmed and On-Demand Cancer Treatment: An Overview on the Emerging Materials,” Chemical Engineering Journal 433 (2022): 134569. b) H. Ding, P. Tan, S. Fu, et al., “Preparation and Application of pH-Responsive Drug Delivery Systems,” Journal of Controlled Release 348 (2022): 206.

[94] P. Ma, H. Xiao, C. Yu, et al., “Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species,” Nano Letters 17 (2017): 928.

[95] a) Y. Sun, B. Lyu, C. Yang, et al. “An Enzyme-Responsive and Transformable PD-L1 Blocking Peptide-Photosensitizer Conjugate Enables Efficient Photothermal Immunotherapy for Breast Cancer,” Bioactive Materials 22 (2023): 47-59. b) M.-S. Lee, C. Dennis, I. Naqvi, et al., “Ornithine Aminotransferase Supports Polyamine Synthesis in Pancreatic Cancer,” Nature 616 (2023): 339.

[96] a) I. A. Todkari, A. R. Chandrasekaran, J. A. Punnoose, et al., “Resolving Altered Base-Pairing of RNA Modifications With DNA Nanoswitches,” Nucleic Acids Research 51 (2023): 11291. b) X. Liu, Z. Zhao, W. Li, et al., “Engineering Nucleotidoproteins for Base-Pairing-Assisted Cytosolic Delivery and Genome Editing,” Angewandte Chemie International Edition 62 (2023): e202307664.

[97] a) L. Xu, M. Peng, T. Gao, et al., “Nanoenabled Intracellular Metal Ion Homeostasis Regulation for Tumor Therapy,” Advancement of Science 11 (2024): e2306203. b) S. Yang, Y. Song, Y. Hu, H. Chen, D. Yang, and X. Song, “Multifaceted Roles of Copper Ions in Anticancer Nanomedicine,” Advanced Healthcare Materials 12 (2023): e2300410. c) R. Qian, X. Yi, T. Liu, et al., “Regulation of Ion Homeostasis for Enhanced Tumor Radio-Immunotherapy,” Advancement of Science 10 (2023): e2304092.

RIGHTS & PERMISSIONS

2025 The Author(s). Exploration published by Henan University and John Wiley & Sons Australia, Ltd.